Daniel Elias Kaufmann

Chief, Division of Infectious Diseases

Lausanne University Hospital

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Elias Kaufmann is the Chief of the Division of Infectious Diseases at the University Hospital of Lausanne, Switzerland. His research focuses on infectious diseases, particularly in relation to HIV-1, SARS-CoV-2, and tuberculosis. Recent articles highlight his work on immune responses and the implications of prolonged dosing intervals in hemodialysis patients. Kaufmann's contributions to the field reflect a commitment to advancing our understanding of complex infectious diseases.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (7)

Julia Niessl

Karolinska Institutet

SWEDEN

View details

Morgan Craig

Université de Montréal

CANADA

View details

Andrew A. House

Western University

CANADA

View details

Janet Cunningham

Senior Clinical Lecturer in Psychiatry and Consultant Psychiatrist

Uppsala University

SWEDEN

View details

Jean-Pierre Routy

Professor

McGill University Health Centre

CANADA

View details

Hugo Zeberg

Karolinska Institutet

SWEDEN

View details

Julie Hussin

Université de Montréal

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Elias Kaufmann

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Distinct peripheral pro-inflammatory profile associated with tuberous sclerosis complex and epilepsy.

Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis

CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies.

Artificial antigen-presenting cell system reveals CD28's role in modulating T cell functions during human immunodeficiency virus infection.

Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients.

La révolution des médicaments à action prolongée.

Enhanced detection of antigen-specific T cells by a multiplexed AIM assay.

Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations

Plasma SARS-CoV-2 RNA elimination and RAGE kinetics distinguish COVID-19 severity.

Collaborators (7)

Julia Niessl

Morgan Craig

Andrew A. House

Janet Cunningham

Jean-Pierre Routy

Hugo Zeberg

Julie Hussin

Make your next move.